ERA PerMed was an ERA-Net Cofund that has been running from December 2017 until November 2023 (six years) , supported by 32 partners from 23 countries and cofunded by the European Commission. To align national research strategies, promote excellence, reinforce the competitiveness of European players in PM, and enhance the European collaboration with non-EU countries, national funding organisations agreed to launch Joint Transnational Calls for collaborative innovative research projects in Personalised Medicine (PM).

Coordinator:  Nacional Institute of Health Carlos III – Instituto de Salud Carlos III

ERA PerMed has finalising its journey, but the new launched European Partnership on Personalised Medicine (EP PerMed) is continuing offering funding opportunities in the field of personalised medicine research.

We invite you to have a look to our ERA PerMed Final Brochure in which your will encounter more details of the results achieved by ERA PerMed in its lifetime. 

This project has received funding from the European Union’s Horizon 2020 Research and Innovation Programme under Grant Agreement No. 779282